Terms: = Germ cell tumor AND SDHC, CYBL, 6391, ENSG00000143252, SDH3, PGL3, QPS1, CYB560 AND Treatment
35 results:
1. Succinate: A Serum Biomarker of SDHB-Mutated Paragangliomas and Pheochromocytomas.
Lamy C; Tissot H; Faron M; Baudin E; Lamartina L; Pradon C; Al Ghuzlan A; Leboulleux S; Perfettini JL; Paci A; Hadoux J; Broutin S
J Clin Endocrinol Metab; 2022 Sep; 107(10):2801-2810. PubMed ID: 35948272
[TBL] [Abstract] [Full Text] [Related]
2. Substance P containing peptide gene delivery vectors for specifically transfecting glioma cells mediated by a neurokinin-1 receptor.
Ding G; Wang T; Han Z; Tian L; Cheng Q; Luo L; Zhao B; Wang C; Feng S; Wang L; Meng Z; Meng Q
J Mater Chem B; 2021 Aug; 9(32):6347-6356. PubMed ID: 34251002
[TBL] [Abstract] [Full Text] [Related]
3. The emerging clinical relevance of genomic profiling in neuroendocrine tumours.
Burak GI; Ozge S; Cem M; Gulgun B; Zeynep DY; Atil B
BMC Cancer; 2021 Mar; 21(1):234. PubMed ID: 33676450
[TBL] [Abstract] [Full Text] [Related]
4. Head and neck paragangliomas in Norway, importance of genetics, updated diagnostic workup and treatment.
Rana MU; Østhus AA; Heimdal K; Jebsen P; Revheim MR; Osnes TA
Acta Otolaryngol; 2021 Mar; 141(3):303-308. PubMed ID: 33320715
[TBL] [Abstract] [Full Text] [Related]
5. The Changing Paradigm of Head and Neck Paragangliomas: What Every Otolaryngologist Needs to Know.
Cass ND; Schopper MA; Lubin JA; Fishbein L; Gubbels SP
Ann Otol Rhinol Laryngol; 2020 Nov; 129(11):1135-1143. PubMed ID: 32486832
[TBL] [Abstract] [Full Text] [Related]
6. Malignant Intrarenal/Renal Pelvis Paraganglioma with Co-Occurring SDHB and ATRX Mutations.
Irwin T; Konnick EQ; Tretiakova MS
Endocr Pathol; 2019 Dec; 30(4):270-275. PubMed ID: 31705439
[TBL] [Abstract] [Full Text] [Related]
7. Pheochromocytoma and paraganglioma: implications of germline mutation investigation for treatment, screening, and surveillance.
Gómez AM; Soares DC; Costa AAB; Pereira DP; Achatz MI; Formiga MN
Arch Endocrinol Metab; 2019 Jul; 63(4):369-375. PubMed ID: 31365623
[TBL] [Abstract] [Full Text] [Related]
8. Pheochromocytoma, paragangliomas, and pituitary adenoma: An unusual association in a patient with an SDHD mutation. Case report.
Lemelin A; Lapoirie M; Abeillon J; Lasolle H; Giraud S; Philouze P; Ceruse P; Raverot G; Vighetto A; Borson-Chazot F
Medicine (Baltimore); 2019 Jul; 98(30):e16594. PubMed ID: 31348302
[TBL] [Abstract] [Full Text] [Related]
9. SDHx-related pheochromocytoma/paraganglioma - genetic, clinical, and treatment outcomes in a series of 30 patients from a single center.
Donato S; Simões H; Pinto AT; M Cavaco B; Leite V
Endocrine; 2019 Aug; 65(2):408-415. PubMed ID: 31104306
[TBL] [Abstract] [Full Text] [Related]
10. The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma.
Kong G; Schenberg T; Yates CJ; Trainer A; Sachithanandan N; Iravani A; Ravi Kumar A; Hofman MS; Akhurst T; Michael M; Hicks RJ
J Clin Endocrinol Metab; 2019 Nov; 104(11):5091-5099. PubMed ID: 30977831
[TBL] [Abstract] [Full Text] [Related]
11. What determines mortality in malignant pheochromocytoma? - Report of a case with eighteen-year survival and review of the literature.
Andrade MO; Cunha VSD; Oliveira DC; Moraes OL; Lofrano-Porto A
Arch Endocrinol Metab; 2018; 62(2):264-269. PubMed ID: 29768630
[TBL] [Abstract] [Full Text] [Related]
12. Succinate dehydrogenase (SDH) deficiency, Carney triad and the epigenome.
Settas N; Faucz FR; Stratakis CA
Mol Cell Endocrinol; 2018 Jul; 469():107-111. PubMed ID: 28739378
[TBL] [Abstract] [Full Text] [Related]
13. Utility of βhCG monitoring in the follow-up of medical management of miscarriage.
Petersen SG; Perkins AR; Gibbons KS; Bertolone JI; Mahomed K
Aust N Z J Obstet Gynaecol; 2017 Jun; 57(3):358-365. PubMed ID: 28345139
[TBL] [Abstract] [Full Text] [Related]
14. Hyperacetylation of histone H3K9 involved in the promotion of abnormally high transcription of the gdnf gene in glioma cells.
Yu ZQ; Zhang BL; Ni HB; Liu ZH; Wang JC; Ren QX; Mo JB; Xiong Y; Yao RQ; Gao DS
Mol Neurobiol; 2014 Dec; 50(3):914-22. PubMed ID: 24619502
[TBL] [Abstract] [Full Text] [Related]
15. Transcriptional regulation of human USP24 gene expression by NF-kappa B.
Wang K; Liu S; Wang J; Wu Y; Cai F; Song W
J Neurochem; 2014 Mar; 128(6):818-28. PubMed ID: 24286619
[TBL] [Abstract] [Full Text] [Related]
16. Connecting molecular pathways to hereditary cancer risk syndromes.
Testa JR; Malkin D; Schiffman JD
Am Soc Clin Oncol Educ Book; 2013; ():81-90. PubMed ID: 23714463
[TBL] [Abstract] [Full Text] [Related]
17. Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations.
Fruhmann J; Geigl JB; Konstantiniuk P; Cohnert TU
Eur J Vasc Endovasc Surg; 2013 May; 45(5):431-6. PubMed ID: 23433498
[TBL] [Abstract] [Full Text] [Related]
18. Head and neck paragangliomas: clinical and molecular genetic classification.
Offergeld C; Brase C; Yaremchuk S; Mader I; Rischke HC; Gläsker S; Schmid KW; Wiech T; Preuss SF; Suárez C; Kopeć T; Patocs A; Wohllk N; Malekpour M; Boedeker CC; Neumann HP
Clinics (Sao Paulo); 2012; 67 Suppl 1(Suppl 1):19-28. PubMed ID: 22584701
[TBL] [Abstract] [Full Text] [Related]
19. Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL).
Zovato S; Kumanova A; Demattè S; Sansovini M; Bodei L; Di Sarra D; Casagranda E; Severi S; Ambrosetti A; Schiavi F; Opocher G; Paganelli G
Horm Metab Res; 2012 May; 44(5):411-4. PubMed ID: 22566197
[TBL] [Abstract] [Full Text] [Related]
20. [Paragangliomas and paraganglioma syndromes].
Boedeker CC
Laryngorhinootologie; 2011 Mar; 90 Suppl 1():S56-82. PubMed ID: 21523634
[TBL] [Abstract] [Full Text] [Related]
[Next]
